Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Handelsblatt

May 25, 2020

Covid-19-Medikament ABX464 wird in Deutschland getestet

Forbes

May 21, 2020

Investors Search for Promising Covid Cures

Biotech Finances

May 18, 2020

15h Biotech Express lundi : Conférence Biotech Finances, Abivax, Néovacs, OSE Immunotherapeutics, Bone Therapeutics, Horama

MyPharma Editions

May 18, 2020

Abivax : 36 millions d’euros de financement de Bpifrance pour son programme ABX464-Covid-19

Industrie Pharma

May 18, 2020

Covid-19 : Bpifrance mise 36 millions d’euros sur Abivax

  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn